Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/27/12 → 12/15/15 |
Funding
- Parexel International LLC: $5,375.00
BMS: A Phase 3, Randomized, Open Label of Lenalidomide/Dexamethasone With or Without Elotuzumab in Subjects with Prevsiouly Untreated Multiple Myeloma
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Richard, Shambavi (CoPI)
Project: Research